ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Salofalk 3 g, Granulat - 90
55951001 Dr. Falk Pharma AG
Salofalk 3 g, Granulat18.09.2003
  18.09.2012
Mesalazine (A07EC02)25.02.2008
WHO-DDD 
04.09.90
04.09. 
B  
Yes 
IPCI
199.05No
    
10 %232.90
7680559510019Synthetika
  
Composition
mesalazinum 3000 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum, E 171, aromatica (Vanille-Creme), aspartamum 6 mg, ad granulatum, pro charta 5.58 g corresp. natrium 9.72 mg.
Packungsbestandteile
Granulate 
  
 
Active AgentDose
Mesalazine3000 mg
BAG: Active AgentDose
Mesalazine3000 mg
 
Inactive agentsDoseadditional_information
   
   
Citric Acid  
   
   
   
Aspartame6 mg 
Carmellose Sodium  
   
  color.
Hypromellosum  
   
   
   
Povidone  
Silica Colloidalis Anhydrica  
Simeticone  
Talcum  
   
 
Source
Data was imported : 04.11.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home